Literature DB >> 15163106

Epidemiology of extra-articular manifestations in rheumatoid arthritis.

C Turesson1, L T H Jacobsson.   

Abstract

Extra-articular RA (ExRA) includes a wide variety of disease manifestations. Although rheumatologists in general are aware that such events are clinically important, the heterogeneity of available data, including discrepancies in case definitions, has complicated constructive discussions on this aspect of the RA disease phenotype. In recent years, there has been a growing recognition of the importance of co-morbidity in patients with RA. ExRA manifestations are not uncommon, explain excess mortality in RA and are predicted by smoking and autoantibodies. Further studies of the mechanisms underlying these associations are likely to be important in improving our understanding of the systemic nature of RA. This article discusses the methodological issues involved in the study of ExRA manifestations, presents suggested criteria that have been used in clinical studies, and reviews important surveys of the epidemiology of extra-articular RA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163106     DOI: 10.1080/03009740310004621

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  45 in total

1.  Anti-citrullinated heat shock protein 90 antibodies identified in bronchoalveolar lavage fluid are a marker of lung-specific immune responses.

Authors:  Lisa Harlow; Bernadette R Gochuico; Ivan O Rosas; Tracy J Doyle; Juan C Osorio; Timothy S Travers; Carlos C Camacho; Chester V Oddis; Dana P Ascherman
Journal:  Clin Immunol       Date:  2014-08-19       Impact factor: 3.969

Review 2.  Rheumatoid Vasculitis: A Diminishing Yet Devastating Menace.

Authors:  Shweta Kishore; Lisa Maher; Vikas Majithia
Journal:  Curr Rheumatol Rep       Date:  2017-07       Impact factor: 4.592

Review 3.  [Systemic manifestations of rheumatoid arthritis].

Authors:  M Uffmann
Journal:  Radiologe       Date:  2006-05       Impact factor: 0.635

4.  Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort.

Authors:  C Turesson; K Eberhardt; L T H Jacobsson; E Lindqvist
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

5.  [Pulmonary fibrosis].

Authors:  A Prasse; J U Holle; J Müller-Quernheim
Journal:  Internist (Berl)       Date:  2010-01       Impact factor: 0.743

6.  Diastolic heart function in RA patients.

Authors:  M Wislowska; B Jaszczyk; M Kochmański; S Sypuła; M Sztechman
Journal:  Rheumatol Int       Date:  2007-10-24       Impact factor: 2.631

7.  Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database.

Authors:  Hans Petri; Debra Maldonato; Noah Jamie Robinson
Journal:  BMC Musculoskelet Disord       Date:  2010-10-25       Impact factor: 2.362

8.  Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: an observational cohort study.

Authors:  Dimitrios A Pappas; Jon T Giles; Geoffrey Connors; Noah Lechtzin; Joan M Bathon; Sonye K Danoff
Journal:  Arthritis Res Ther       Date:  2010-05-27       Impact factor: 5.156

9.  Extensive Citrullination Promotes Immunogenicity of HSP90 through Protein Unfolding and Exposure of Cryptic Epitopes.

Authors:  Timothy S Travers; Lisa Harlow; Ivan O Rosas; Bernadette R Gochuico; Ted R Mikuls; Sanjoy K Bhattacharya; Carlos J Camacho; Dana P Ascherman
Journal:  J Immunol       Date:  2016-07-22       Impact factor: 5.422

10.  Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis.

Authors:  José Félix Restrepo; Inmaculada del Rincón; Daniel F Battafarano; Roy W Haas; Merced Doria; Agustín Escalante
Journal:  Clin Rheumatol       Date:  2015-08-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.